Commercial T-cell testing reveals factors correlated with decreased T-cell responses to SARS-CoV-2 in clinical trial subjects
Washington, DC – June 11, 2022 – T cell testing using a commercial T cell test, QuantiFERON SARS-CoV-2 RUO, provides information on the immune response to infection and vaccination of patients with COVID-19 and suggests that age and time since infection are important factors related to the magnitude of cell-mediated immune responses (MICs) to COVID-19. …